Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

The technology vendor’s vantage point: bye bye Excel, hello transparency and new generation of fund managers

Wednesday, July 21, 2010

Benedicte Gravrand, Opalesque London:

Advent Software, a technology provider headquartered in San Francisco with fingers on the hedge fund industry’s pulses (mainly hedge fund managers, fund administrators and prime brokers) has seen a lot of traction in the U.S. as well as in Europe - especially since the end of 2008.

The reason for that has predominantly been an increasing need for infrastructure, Chris Cattermole, Advent’s EMEA sales manager told Opalesque in a recent interview in Advent’s London offices. As indeed, hedge funds are having to build out more operational efficiency and cater for due diligence demands from the new institutional investors.

“Hedge funds are really trying to reduce their use of Excel spread-sheets, trying to focus on automation and making sure that they have an efficient operational environment, as well as procedures that would appeal to the end investors,” he said.

Bye bye Excel Before 2008, institutional investors’ operational due diligence process used to be a check-box exercise with questions like ‘what asset classes do you trade’, ‘which investments do you do’, ‘what is your staff’s experience,’ according to Cattermole. Now, due diligence is more assertive and asks questions such as ‘do you invest in swaps’, ‘how do you track them’, ‘how do you track the financing behind the swaps’, ‘what systems and what expertise and what intellectual property do you have in operations to cater for those asset cla......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its